This is reassuring since the majority of neoplasms that do not carry driver alterations within strong epigenomic modifiers (e.g., IDH1/2, SMARCB1) largely retain epigenomic features of their precursor lineages [17]. This evidence concerns the gene IDH1 and neoplasm.